Below are some of the unlisted options held by Nina (per annual report):
Nina is a very competent CEO/MD, if Phase3 trial is successful, she should be rewarded in some way imo even if the above options are fully expired/lapsed (looks like so. just don't understand why they initially put expiry date on exactly same time/date yet with different exercise prices hope it was a mistake and the expiry date with higher exe price is actually in a bit later years)..
Ann: Dimerix Announces License Agreement for EU, Canada, ANZ, page-343
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $209.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.3¢ | 36.5¢ | $39.65K | 107.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 91271 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 22285 | 3 |
View Market Depth
| Last trade - 10.32am 18/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |